Trade Summary

2 days ago, O'Day Daniel Patrick, serving as COB, CEO at Gilead Sciences, Inc. (GILD), sold 10,000 shares at $124.83 per share, for a total transaction value of $1,248,272.00. Following this transaction, O'Day Daniel Patrick now holds 566,698 shares of GILD.

This sale represents a 2.00% decrease in O'Day Daniel Patrick's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, December 29, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, December 30, 2025, 1 day after the trade was made.

Gilead Sciences, Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - GENERAL industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.